APAC Industry Committee

Asia Pacific Industry Committee

The Committee

The APAC Industry Committee was established in joint with the ISCT Asia Regional Executive Committee and ISCT Industry Leadership.

Charter

The Asia Pacific Industry Committee (APAC) strives to:

  • address the unique challenges in cell and gene product development in the Asia Pacific Region.

Projects & Objectives

  • The APAC Industry Committee presented a roundtable at ISCT 2022 examining global market strategies and regulatory considerations for entering the APAC Market.
  • Monthly meeting discussions focus on global partnerships, regional regulatory considerations, process development challenges and more.

Headshot of Anthony Ting


Chair

William (Bill) Milligan, BSc

Steminent Biotherapeutics
Taiwan/Canada


2024 Members

Hermann Bohnenkamp
Miltenyi Biotec

Bingrong Chen
Thermo Fisher Scientific

Vorapin Chin
ESP

Bryan Choi
ExOfficio Asia Regional Committee

Lynn Csontos
STEMCELL Technologies

Alannah Evans
KITE

Pawan Gupta
Stempeutics Research

Shin Kawamata
Cyto-Facto Inc.

Wenyan Leong
Terumo BCT

Michael May
CCRM

Chris McClain
NMDP

John NG
Dark Horse Consulting

Steve Oh
Independent Cell Therapy Consultant

Karolis Rosickas
Regeneus Ltd.

Gayatri Sharma
Cellvec

Mitchel Sivilotti
OmniaBio

Nathan Smith
Cell Therapies Pty

Kunihiko Suzuki
MEDINET Co LTD.

Dan Swanson
cGMPnow

Eddie Tan
ESP

Yoshie Tsurumaki
FIRM

Franziska Uber
PL BioScience GmhH

Zlatibor Velickovic
Royal Perth Hospital

William YK Hwang
SingHealth

Peiqing Zhan
Cytiva